- Home
- SFWL vs COYA Comparison
SFWL vs COYA Comparison
Compare SFWL & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SFWL
- COYA
- Stock Information
- Founded
- SFWL 2001
- COYA 2020
- Country
- SFWL China
- COYA United States
- Employees
- SFWL N/A
- COYA N/A
- Industry
- SFWL Trucking Freight/Courier Services
- COYA Biotechnology: Pharmaceutical Preparations
- Sector
- SFWL Industrials
- COYA Health Care
- Exchange
- SFWL Nasdaq
- COYA Nasdaq
- Market Cap
- SFWL 114.7M
- COYA 104.3M
- IPO Year
- SFWL 2023
- COYA 2022
- Fundamental
- Price
- SFWL $1.11
- COYA $6.50
- Analyst Decision
- SFWL
- COYA Strong Buy
- Analyst Count
- SFWL 0
- COYA 3
- Target Price
- SFWL N/A
- COYA $16.67
- AVG Volume (30 Days)
- SFWL 80.2K
- COYA 143.6K
- Earning Date
- SFWL 09-04-2024
- COYA 11-06-2024
- Dividend Yield
- SFWL N/A
- COYA N/A
- EPS Growth
- SFWL N/A
- COYA N/A
- EPS
- SFWL 0.11
- COYA N/A
- Revenue
- SFWL $446,281,000.00
- COYA $9,554,315.00
- Revenue This Year
- SFWL N/A
- COYA N/A
- Revenue Next Year
- SFWL N/A
- COYA $54.20
- P/E Ratio
- SFWL $10.77
- COYA N/A
- Revenue Growth
- SFWL 14.80
- COYA N/A
- 52 Week Low
- SFWL $0.81
- COYA $4.75
- 52 Week High
- SFWL $15.94
- COYA $10.69
- Technical
- Relative Strength Index (RSI)
- SFWL 30.55
- COYA 44.11
- Support Level
- SFWL $1.25
- COYA $5.90
- Resistance Level
- SFWL $1.26
- COYA $7.50
- Average True Range (ATR)
- SFWL 0.08
- COYA 0.50
- MACD
- SFWL -0.02
- COYA -0.12
- Stochastic Oscillator
- SFWL 3.57
- COYA 36.36
About SFWL Shengfeng Development Limited
Shengfeng Development Ltd is a holding company. The company offers contract logistics services comprising planning and designing supply chains, designing facilities, processing orders, collecting payments, managing inventories, and providing client services. The integrated logistics solution services of the company are comprised of three segments: B2B freight transportation; cloud storage; and value-added services.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.